查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1855814

2025年全球心血管基因体学检测组合市场报告

Cardiogenomics Testing Panels Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，心臟基因组学检测市场发展迅速，预计到2024年将达到13.8亿美元，到2025年将达到15.5亿美元，复合年增长率为12.7%。预测期内的成长归因于基因检测报销政策的扩大、基因咨询服务的增加、对早期诊断和预防的重视、公众意识提升的提高以及远端医疗和远距离诊断的广泛应用。

预计未来几年，心血管基因组学检测市场将快速成长，到2029年市场规模将达到24.8亿美元，复合年增长率（CAGR）为12.4%。预测期内的成长主要归因于心血管疾病盛行率的上升、人们对遗传易感性的认识不断提高、个人化医疗需求的成长、次世代定序仪的普及以及医疗保健领域对基因组学投资的增加。预测期内的关键趋势包括次世代定序仪的发展、人工智慧在数据分析中的应用、多基因检测组合的开发、微阵列技术的进步以及基因组数据在电子健康记录中的整合。

心血管基因组学检测是一种基因检测，它检查多个基因，以确定您患心血管疾病（如心肌病、心律不整和遗传性高胆固醇症）的遗传风险，从而支持早期诊断、个人化治疗和家族风险评估。

心血管基因组学检测主要分为单基因检测、多基因检测和全EXOME显子定序。单基因检测针对特定基因，检测与特定遗传疾病相关的突变或变异。所采用的技术包括次世代定序、基于PCR的检测和微阵列技术。这些检测被医院、诊所、诊断实验室、学术和研究机构以及其他终端使用者用于遗传性心血管疾病、心律不整、心肌病和先天性心臟疾病等领域。

美国关税的快速上涨以及持续到2025年春季的贸易摩擦，对医疗设备行业产生了重大影响，尤其是进口诊断成像设备部件、手术用不銹钢和塑胶耗材。医院和诊所抵制价格上涨，挤压了製造商的净利率。监管障碍加剧了这个问题，因为与关税相关的供应商变更通常需要重新认证设备，从而延缓产品上市时间。企业正透过关键零件的双重采购、扩大国内同质化产品的生产以及加速研发经济高效材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）最新系列报告的一部分，提供心血管基因组学检测组合市场统计数据，包括全球市场规模、区域份额、竞争对手及其市场份额、详细的市场细分、市场趋势和机会，以及您在心血管基因组学检测组合行业取得成功所需的数据。本心血管基因组学检测组合市场研究报告对该行业的现状和未来发展趋势进行了详细分析，为您提供所需的一切观点。

遗传性心血管疾病盛行率的上升预计将推动心臟基因组检测市场的成长。遗传性心血管疾病（ICD）包括由父母遗传给子女的心臟和血管疾病。基因检测和诊断技术的进步使得以往难以发现的疾病能够被更准确地检测到，从而导致确诊病例的增加。心臟基因组检测心臟疾病的诊疗提供支持，有助于早期诊断、风险评估和个人化治疗方案的发展。例如，英国社区健康中心联合战略需求评估中心（Joint Strategic Needs Assessment）在2025年2月发布的报告显示，布莱克浦2023年记录的心血管疾病死亡人数为185人，而2022年为178人。这种盛行率的上升正在推动心臟基因组检测市场的扩张。

预计医疗保健支出的成长将推动心血管基因组学检测市场的发展。医疗保健支出包括政府、私人机构和个人用于提供、维护和改善医疗保健服务的总资源。支出成长的驱动因素是慢性疾病负担日益加重，这些疾病需要长期管理、持续监测和专业介入。这些支出透过资助先进的基因分析来支持心血管基因组学检测，从而实现遗传性心血管疾病的早期发现和预防，改善患者预后并降低长期成本。例如，美国联邦政府机构医疗保险和医疗补助服务中心（CMS）于2023年12月报告称，2022年美国医疗保健支出将增加4.1%，达到4.5兆美元，高于2021年的3.2%。这一趋势正在推动心血管基因组学检测市场的成长。

2022年3月，美国医疗保健解决方案供应商LetsGetChecked收购了Veritas Genetics Inc.和Veritas Intercontinental SL，具体金额未揭露。此次收购旨在利用全基因组定序技术，将详细的基因数据整合到可扩展的诊断和虚拟护理平台中，从而提供全面、个人化的医疗保健生命週期服务，并由临床专家提供切实可行的建议和生活方式指导。 Veritas Genetics Inc.和Intercontinental SL是两家提供心臟基因组学检测的美国生物技术公司。

心血管基因组学检测市场由提供基因风险评估、早期诊断和个人化治疗方案等服务的营业单位所获得的收入组成。市场价值还包括服务供应商销售的或包含在其服务中的相关产品的价值。心血管基因组学检测市场还包括综合性心肌病检测组合、心律不整检测组合以及直接面向消费者的基因组分析的销售额。此市场价值为“出厂价”，即产品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的产品价值。该市场中的产品价值还包括产品製造商提供的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球心血管基因组学检测小组：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球心血管基因组学检测市场：成长率分析
  • 全球心血管基因体学检测组合市场表现：规模与成长，2019-2024年
  • 全球心血管基因组学检测组合市场预测：规模与成长，2024-2029年，2034年预测
  • 全球心血管基因组学检测组合：潜在市场规模 (TAM)

第六章 市场细分

  • 全球心血管基因体学检测组合市场依产品类型、效能及预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 单基因检测
  • 多基因检测
  • 全EXOME定序panel
  • 全球心血管基因体学检测组合市场（依技术划分）：绩效及预测，2019-2024年、2024-2029年预测、2034年预测
  • 次世代定序仪
  • 基于PCR的检测
  • 微阵列
  • 其他技术
  • 全球心血管基因体学检测组合市场：按应用、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 遗传性心血管疾病
  • 心律不整
  • 心肌病
  • 先天性心臟疾病
  • 其他应用
  • 全球心血管基因体学检测组合市场：依最终用户划分，实际值及预测值，2019-2024年、2024-2029年预测值、2034年预测值
  • 医院和诊所
  • 诊断实验室
  • 学术研究机构
  • 其他最终用户
  • 全球心血管基因组学检测组合市场：按单基因组合、类型、性能和预测进行细分，2019-2024年、2024-2029年预测、2034年预测
  • 离子通道基因检测
  • 结构性心臟病基因检测
  • 心律不整基因检测
  • 全球心血管基因组学检测组合市场：按多基因组合、类型、性能和预测进行细分，2019-2024年、2024-2029年预测、2034年预测
  • 心肌病专家组
  • 心律不整小组
  • 先天性心臟疾病医师组
  • 全球心血管基因组学检测组合市场：细分：全EXOME序组合，按类型、表现和预测（2019-2024 年、2024-2029 年预测、2034 年预测）
  • 标靶心血管EXOME组检测
  • 全面EXOME组检测
  • 研究EXOME面板

第七章 区域和国家分析

  • 全球心血管基因体学检测组合市场：按地区、绩效及预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 全球心血管基因体学检测组合市场：按国家/地区、绩效和预测划分，2019-2024 年、2024-2029 年预测、2034 年预测

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 心血管基因组学检测组合市场：竞争格局
  • 心血管基因组学检测市场：公司概况
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific, Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Illumina Inc.
  • Actia Group
  • Invitae Corporation
  • Fulgent Genetics Inc.
  • GeneDx Inc.
  • Ambry Genetics Corporation
  • Helix OpCo Inc.
  • Centogene Gmbh
  • Blueprint Genetics Inc.
  • Strand Life Sciences Pvt. Ltd.
  • Genes2Me Pvt. Ltd.
  • BioAro Inc.
  • GENinCode Plc
  • Igenomix SL
  • Asper Biotech Ltd.

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年心血管基因体学检测市场：提供新机会的国家
  • 2029年心血管基因体学检测组合市场：新兴细分市场机会
  • 2029年心血管基因组学检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r38463

Cardiogenomics testing panels are genetic tests that examine multiple genes to determine inherited risks for cardiovascular diseases, including cardiomyopathies, arrhythmias, and familial hypercholesterolemia. They support early diagnosis, personalized treatment, and assessment of family risk.

The primary product types of cardiogenomics testing panels are single-gene panels, multi-gene panels, and whole exome sequencing panels. Single-gene panels test a specific gene to detect mutations or variants linked to a particular inherited condition or disease. The technologies employed include next-generation sequencing, PCR-based testing, microarrays, and others. These panels are applied in areas such as inherited cardiovascular diseases, arrhythmias, cardiomyopathies, congenital heart diseases, and others, and are used by hospitals and clinics, diagnostic laboratories, academic and research institutions, and other end users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The cardiogenomics testing panels market research report is one of a series of new reports from The Business Research Company that provides cardiogenomics testing panels market statistics, including cardiogenomics testing panels industry global market size, regional shares, competitors with a cardiogenomics testing panels market share, detailed cardiogenomics testing panels market segments, market trends and opportunities, and any further data you may need to thrive in the cardiogenomics testing panels industry. This cardiogenomics testing panels market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiogenomics testing panels market size has grown rapidly in recent years. It will grow from $1.38 billion in 2024 to $1.55 billion in 2025 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to expanding reimbursement policies for genetic tests, an increasing number of genetic counseling services, greater focus on early diagnosis and prevention, rising public awareness initiatives, and wider adoption of telemedicine and remote diagnostics.

The cardiogenomics testing panels market size is expected to see rapid growth in the next few years. It will grow to $2.48 billion in 2029 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to the increasing prevalence of cardiovascular diseases, growing awareness of genetic predispositions, higher demand for personalized medicine, greater availability of next-generation sequencing, and rising healthcare investments in genomics. Key trends in the forecast period include advancements in next-generation sequencing, integration of artificial intelligence for data analysis, development of multi-gene panels, progress in microarray technology, and incorporation of genomic data with electronic health records.

The rising prevalence of inherited cardiovascular diseases is expected to drive growth in the cardiogenomics testing panels market. Inherited cardiovascular diseases (ICDs) include heart and blood vessel disorders passed down genetically from parents to offspring. Advances in genetic testing and diagnostics have contributed to an increase in diagnosed cases by enabling more precise detection of previously unidentified conditions. Cardiogenomics testing panels assist in inherited cardiovascular diseases by analyzing genetic mutations responsible for hereditary heart disorders, facilitating early diagnosis, risk evaluation, and personalized treatment plans. For example, in February 2025, the Joint Strategic Needs Assessment, a UK community health center, reported that Blackpool recorded 185 cardiovascular disease deaths in 2023 compared to 178 in 2022. This growing prevalence is fueling expansion in the cardiogenomics testing panels market.

Increasing healthcare expenditure is anticipated to boost the cardiogenomics testing panels market. Healthcare expenditure encompasses the total resources spent by governments, private entities, and individuals on delivering, maintaining, and improving health services and medical care. The rise in spending is driven by the growing burden of chronic diseases that require long-term management, ongoing monitoring, and specialized interventions. These expenditures support cardiogenomics testing panels by funding advanced genetic analyses that enable early detection and prevention of inherited cardiovascular conditions, improving patient outcomes and lowering long-term costs. For instance, in December 2023, the Centers for Medicare & Medicaid Services, a US federal agency, reported that healthcare spending in the US increased by 4.1% in 2022, reaching $4.5 trillion, up from 3.2% growth in 2021. This trend contributes to market growth in cardiogenomics testing panels.

In March 2022, LetsGetChecked, a US healthcare solutions provider, acquired Veritas Genetics Inc. and Veritas Intercontinental S.L. for an undisclosed amount. This acquisition aims to utilize whole genome sequencing to offer a comprehensive personalized healthcare lifecycle by integrating detailed genetic data into scalable diagnostic and virtual care platforms, delivering actionable recommendations and lifestyle guidance from clinical experts. Veritas Genetics Inc. and Intercontinental S.L. are US-based biotechnology firms providing cardiogenomics testing panels.

Major players in the cardiogenomics testing panels market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Illumina Inc., Actia Group, Invitae Corporation, Fulgent Genetics Inc., GeneDx Inc., Ambry Genetics Corporation, Helix OpCo Inc., Centogene Gmbh, Blueprint Genetics Inc., Strand Life Sciences Pvt. Ltd., Genes2Me Pvt. Ltd., BioAro Inc., GENinCode Plc, Igenomix S.L., Asper Biotech Ltd.

North America was the largest region in the cardiogenomics testing panels market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cardiogenomics testing panels report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cardiogenomics testing panels market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiogenomics testing panels market consists of revenues earned by entities by providing services such as genetic risk assessment, early diagnosis, and personalized treatment planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiogenomics testing panels market also includes sales of comprehensive cardiomyopathy panels, cardiac arrhythmia panels, and direct-to-consumer genomic profiles. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiogenomics Testing Panels Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiogenomics testing panels market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiogenomics testing panels ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiogenomics testing panels market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Single-Gene Panels; Multi-Gene Panels; Whole Exome Sequencing Panels
  • 2) By Technology: Next-Generation Sequencing; PCR-Based Testing; Microarray; Other Technologies
  • 3) By Application: Inherited Cardiovascular Diseases; Arrhythmias; Cardiomyopathies; Congenital Heart Diseases; Other Appications
  • 4) By End User: Hospitals And Clinics; Diagnostic Laboratories; Academic And Research Institutes; Other End Users
  • Subsegments:
  • 1) By Single-Gene Panels: Ion Channel Gene Panels; Structural Heart Disease Gene Panels; Arrhythmia Gene Panels
  • 2) By Multi-Gene Panels: Cardiomyopathy Panels; Arrhythmia Panels; Congenital Heart Disease Panels
  • 3) By Whole Exome Sequencing Panels: Targeted Cardiovascular Exome Panels; Comprehensive Exome Panels; Research-Oriented Exome Panels
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific, Inc.; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Eurofins Scientific SE; Illumina Inc.; Actia Group; Invitae Corporation; Fulgent Genetics Inc.; GeneDx Inc.; Ambry Genetics Corporation; Helix OpCo Inc.; Centogene Gmbh; Blueprint Genetics Inc.; Strand Life Sciences Pvt. Ltd.; Genes2Me Pvt. Ltd.; BioAro Inc.; GENinCode Plc; Igenomix S.L.; Asper Biotech Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiogenomics Testing Panels Market Characteristics

3. Cardiogenomics Testing Panels Market Trends And Strategies

4. Cardiogenomics Testing Panels Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cardiogenomics Testing Panels Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cardiogenomics Testing Panels PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cardiogenomics Testing Panels Market Growth Rate Analysis
  • 5.4. Global Cardiogenomics Testing Panels Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cardiogenomics Testing Panels Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cardiogenomics Testing Panels Total Addressable Market (TAM)

6. Cardiogenomics Testing Panels Market Segmentation

  • 6.1. Global Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Gene Panels
  • Multi-Gene Panels
  • Whole Exome Sequencing Panels
  • 6.2. Global Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencing
  • PCR-Based Testing
  • Microarray
  • Other Technologies
  • 6.3. Global Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Inherited Cardiovascular Diseases
  • Arrhythmias
  • Cardiomyopathies
  • Congenital Heart Diseases
  • Other Appications
  • 6.4. Global Cardiogenomics Testing Panels Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Academic And Research Institutes
  • Other End Users
  • 6.5. Global Cardiogenomics Testing Panels Market, Sub-Segmentation Of Single-Gene Panels, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ion Channel Gene Panels
  • Structural Heart Disease Gene Panels
  • Arrhythmia Gene Panels
  • 6.6. Global Cardiogenomics Testing Panels Market, Sub-Segmentation Of Multi-Gene Panels, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiomyopathy Panels
  • Arrhythmia Panels
  • Congenital Heart Disease Panels
  • 6.7. Global Cardiogenomics Testing Panels Market, Sub-Segmentation Of Whole Exome Sequencing Panels, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Targeted Cardiovascular Exome Panels
  • Comprehensive Exome Panels
  • Research-Oriented Exome Panels

7. Cardiogenomics Testing Panels Market Regional And Country Analysis

  • 7.1. Global Cardiogenomics Testing Panels Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cardiogenomics Testing Panels Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiogenomics Testing Panels Market

  • 8.1. Asia-Pacific Cardiogenomics Testing Panels Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiogenomics Testing Panels Market

  • 9.1. China Cardiogenomics Testing Panels Market Overview
  • 9.2. China Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiogenomics Testing Panels Market

  • 10.1. India Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiogenomics Testing Panels Market

  • 11.1. Japan Cardiogenomics Testing Panels Market Overview
  • 11.2. Japan Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiogenomics Testing Panels Market

  • 12.1. Australia Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiogenomics Testing Panels Market

  • 13.1. Indonesia Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiogenomics Testing Panels Market

  • 14.1. South Korea Cardiogenomics Testing Panels Market Overview
  • 14.2. South Korea Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiogenomics Testing Panels Market

  • 15.1. Western Europe Cardiogenomics Testing Panels Market Overview
  • 15.2. Western Europe Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiogenomics Testing Panels Market

  • 16.1. UK Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiogenomics Testing Panels Market

  • 17.1. Germany Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiogenomics Testing Panels Market

  • 18.1. France Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiogenomics Testing Panels Market

  • 19.1. Italy Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiogenomics Testing Panels Market

  • 20.1. Spain Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiogenomics Testing Panels Market

  • 21.1. Eastern Europe Cardiogenomics Testing Panels Market Overview
  • 21.2. Eastern Europe Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiogenomics Testing Panels Market

  • 22.1. Russia Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiogenomics Testing Panels Market

  • 23.1. North America Cardiogenomics Testing Panels Market Overview
  • 23.2. North America Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiogenomics Testing Panels Market

  • 24.1. USA Cardiogenomics Testing Panels Market Overview
  • 24.2. USA Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiogenomics Testing Panels Market

  • 25.1. Canada Cardiogenomics Testing Panels Market Overview
  • 25.2. Canada Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiogenomics Testing Panels Market

  • 26.1. South America Cardiogenomics Testing Panels Market Overview
  • 26.2. South America Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiogenomics Testing Panels Market

  • 27.1. Brazil Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiogenomics Testing Panels Market

  • 28.1. Middle East Cardiogenomics Testing Panels Market Overview
  • 28.2. Middle East Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiogenomics Testing Panels Market

  • 29.1. Africa Cardiogenomics Testing Panels Market Overview
  • 29.2. Africa Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiogenomics Testing Panels Market Competitive Landscape And Company Profiles

  • 30.1. Cardiogenomics Testing Panels Market Competitive Landscape
  • 30.2. Cardiogenomics Testing Panels Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific, Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

31. Cardiogenomics Testing Panels Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. Actia Group
  • 31.3. Invitae Corporation
  • 31.4. Fulgent Genetics Inc.
  • 31.5. GeneDx Inc.
  • 31.6. Ambry Genetics Corporation
  • 31.7. Helix OpCo Inc.
  • 31.8. Centogene Gmbh
  • 31.9. Blueprint Genetics Inc.
  • 31.10. Strand Life Sciences Pvt. Ltd.
  • 31.11. Genes2Me Pvt. Ltd.
  • 31.12. BioAro Inc.
  • 31.13. GENinCode Plc
  • 31.14. Igenomix S.L.
  • 31.15. Asper Biotech Ltd.

32. Global Cardiogenomics Testing Panels Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiogenomics Testing Panels Market

34. Recent Developments In The Cardiogenomics Testing Panels Market

35. Cardiogenomics Testing Panels Market High Potential Countries, Segments and Strategies

  • 35.1 Cardiogenomics Testing Panels Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cardiogenomics Testing Panels Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cardiogenomics Testing Panels Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer